New targeted therapies for metastatic colorectal cancer have increased the need for awareness, education and training for nurses to prepare them to confidently manage and educate patients. This interactive activity will include a combination of learning strategies to build competencies in the area of diagnostic testing and treatment options.
You will enjoy access for 180 days from date of purchase, after which you will no longer be able to access the course.
Produced by ONS with an educational grant from Pfizer, Inc. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications.
Participants will report improved knowledge regarding the care of patients receiving treatment for mCRC.
The primary target audience for the educational programs includes oncology nurses, advanced practice nurses (APNs) and other healthcare providers involved in the management of patients receiving targeted therapies for mCRC.
Up to 1.0 ILNA points may be applied to Diagnosis and Staging OR Disease-Related Biology OR Treatment. No more than 1.0 total points may be claimed for the program.